Research - Larix decidua
Terebinthina Laricina in Borreliosis: Comparison with Antibiotic Therapies
Im Amann 7, D-88662, Uberlingen, Germany
Lyme disease antibiotic therapy regimens are recommended by the Centres for Disease Control and Prevention, the Infectious Disease Society of America, and the National Institutes of Health. Alternative approaches consist of prolonged antibiotic treatment however Lyme disease often results in persistent Borrelia burgdorferi infection. Continuous antibiotic therapy results in low lymphocyte levels thus cannot be applied for long term without harm.
Objectives: Alternative approaches for treatment of Lyme borreliosis are required, which successfully reduce or erase bacteria without affecting the human cells. Terebinthina laricina, an alcoholic extract of Larix decidua resin was selected for a pilot study to treat a patient with neuroborreliosis.
Results: After six weeks of treatment, the patient shows a strong Herxheimer reaction. No disease progression occurs, within weeks she recovers from most of the Lyme disease specific symptoms. Elispot results indicate no bacterial activity.
Conclusion: This new principle of Lyme disease treatment shows high potential to provide a smooth medical treatment for neuroborreliosis.
Source : Journal of Homeopathy and Ayurvedic Medicine
Link to Full Article